Needham & Company LLC Lowers DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $36.00

DENTSPLY SIRONA (NASDAQ:XRAYFree Report) had its target price cut by Needham & Company LLC from $42.00 to $36.00 in a report issued on Friday, Benzinga reports. They currently have a buy rating on the medical instruments supplier’s stock.

XRAY has been the subject of several other reports. Robert W. Baird decreased their price target on DENTSPLY SIRONA from $35.00 to $33.00 and set a neutral rating for the company in a report on Friday. Leerink Partnrs restated an outperform rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. SVB Leerink initiated coverage on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. They set an outperform rating and a $42.00 price target on the stock. Barrington Research reissued an outperform rating and set a $41.00 price target on shares of DENTSPLY SIRONA in a report on Thursday, April 18th. Finally, StockNews.com raised DENTSPLY SIRONA from a hold rating to a buy rating in a report on Friday, January 19th. Five research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of Moderate Buy and an average price target of $35.89.

Get Our Latest Stock Analysis on DENTSPLY SIRONA

DENTSPLY SIRONA Trading Down 0.3 %

NASDAQ:XRAY opened at $28.29 on Friday. The company has a quick ratio of 0.95, a current ratio of 1.43 and a debt-to-equity ratio of 0.54. DENTSPLY SIRONA has a 52-week low of $26.27 and a 52-week high of $41.65. The stock’s 50 day moving average price is $32.13 and its 200 day moving average price is $32.71. The company has a market capitalization of $5.87 billion, a PE ratio of -64.29, a P/E/G ratio of 1.15 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last announced its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, hitting the consensus estimate of $0.42. The business had revenue of $953.00 million during the quarter, compared to the consensus estimate of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The business’s quarterly revenue was down 2.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.39 earnings per share. On average, research analysts anticipate that DENTSPLY SIRONA will post 2.04 EPS for the current year.

DENTSPLY SIRONA Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were paid a dividend of $0.16 per share. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. The ex-dividend date was Wednesday, March 27th. This represents a $0.64 annualized dividend and a dividend yield of 2.26%. DENTSPLY SIRONA’s payout ratio is -145.45%.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several hedge funds have recently bought and sold shares of the company. GSA Capital Partners LLP purchased a new stake in DENTSPLY SIRONA during the first quarter worth $655,000. Central Pacific Bank Trust Division purchased a new stake in shares of DENTSPLY SIRONA in the 1st quarter worth about $64,000. Financial Counselors Inc. grew its stake in DENTSPLY SIRONA by 4.2% in the 1st quarter. Financial Counselors Inc. now owns 218,576 shares of the medical instruments supplier’s stock valued at $7,255,000 after acquiring an additional 8,793 shares during the last quarter. FORA Capital LLC purchased a new position in DENTSPLY SIRONA during the 1st quarter valued at about $771,000. Finally, Daiwa Securities Group Inc. raised its position in DENTSPLY SIRONA by 7.9% during the first quarter. Daiwa Securities Group Inc. now owns 17,652 shares of the medical instruments supplier’s stock worth $585,000 after acquiring an additional 1,296 shares during the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

(Get Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Articles

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.